- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 4 x JKF: 6-[(R)-(4-chlorophenyl)(methoxy)(1-methyl-1H-imidazol-5-yl)methyl]-4-(2,6-difluorophenyl)-1-methylquinolin-2(1H)-one(Non-covalent)
JKF.2: 13 residues within 4Å:- Chain A: Y.76, F.78, F.83, A.88, Y.89, L.181, F.263, A.264, L.329, M.331, M.433, V.434
- Ligands: HEM.1
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:Y.76, A:F.83, A:Y.89, A:L.181, A:F.263, A:L.329, A:V.434
JKF.4: 15 residues within 4Å:- Chain B: Y.76, F.78, M.79, F.83, A.88, Y.89, L.181, F.263, A.264, T.268, L.329, M.331, M.433, V.434
- Ligands: HEM.3
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:Y.76, B:Y.89, B:L.181, B:F.263, B:A.264, B:V.434
JKF.6: 14 residues within 4Å:- Chain C: Y.76, F.78, M.79, F.83, A.88, Y.89, L.181, F.263, A.264, L.329, M.331, M.433, V.434
- Ligands: HEM.5
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:Y.76, C:F.83, C:Y.89, C:L.181, C:F.263, C:L.329, C:L.329, C:V.434
JKF.8: 16 residues within 4Å:- Chain D: Y.76, F.78, M.79, F.83, A.88, Y.89, L.181, F.263, A.264, T.268, L.329, M.331, L.332, M.433, V.434
- Ligands: HEM.7
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:Y.76, D:F.83, D:Y.89, D:L.181, D:F.263, D:L.329, D:V.434
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Buckner, F.S. et al., Pharmacological characterization, structural studies, and in vivo activities of anti-chagas disease lead compounds derived from tipifarnib. Antimicrob.Agents Chemother. (2012)
- Release Date
- 2012-07-11
- Peptides
- sterol 14-alpha demethylase (CYP51): ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 4 x JKF: 6-[(R)-(4-chlorophenyl)(methoxy)(1-methyl-1H-imidazol-5-yl)methyl]-4-(2,6-difluorophenyl)-1-methylquinolin-2(1H)-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Buckner, F.S. et al., Pharmacological characterization, structural studies, and in vivo activities of anti-chagas disease lead compounds derived from tipifarnib. Antimicrob.Agents Chemother. (2012)
- Release Date
- 2012-07-11
- Peptides
- sterol 14-alpha demethylase (CYP51): ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
D